[
  {
    "ts": null,
    "headline": "Earnings live: United Airlines stock rises on earnings beat; shares of Bank of America, Morgan Stanley, LVMH, and ASML gain",
    "summary": "Third quarter earnings season is just beginning, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finnhub.io/api/news?id=58c106362d59c48bdd4ebead61029d5d2362c5a73c475330f166f9cf90c0ae77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760559642,
      "headline": "Earnings live: United Airlines stock rises on earnings beat; shares of Bank of America, Morgan Stanley, LVMH, and ASML gain",
      "id": 137098006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Third quarter earnings season is just beginning, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
      "url": "https://finnhub.io/api/news?id=58c106362d59c48bdd4ebead61029d5d2362c5a73c475330f166f9cf90c0ae77"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More",
    "summary": "Bank of America and Morgan Stanley beat earnings estimates, while ASML, the Dutch semiconductor-equipment maker, posts better-than-expected third-quarter earnings and issues an upbeat forecast.",
    "url": "https://finnhub.io/api/news?id=1cf2d48de4fb5bdc310bf287281c23a713774653bf9adfaa6627e319cec9713b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760559360,
      "headline": "These Stocks Moved the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More",
      "id": 137101962,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Bank of America and Morgan Stanley beat earnings estimates, while ASML, the Dutch semiconductor-equipment maker, posts better-than-expected third-quarter earnings and issues an upbeat forecast.",
      "url": "https://finnhub.io/api/news?id=1cf2d48de4fb5bdc310bf287281c23a713774653bf9adfaa6627e319cec9713b"
    }
  },
  {
    "ts": null,
    "headline": "Why Abbott Laboratories (ABT) Stock Is Down Today",
    "summary": "Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, but did not exceed, Wall Street's expectations.",
    "url": "https://finnhub.io/api/news?id=165b90b156e5e6993f0d9d20de75f668ecfc6d845f7bdb45e8a8bcc41fbe8bea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760558761,
      "headline": "Why Abbott Laboratories (ABT) Stock Is Down Today",
      "id": 137102012,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, but did not exceed, Wall Street's expectations.",
      "url": "https://finnhub.io/api/news?id=165b90b156e5e6993f0d9d20de75f668ecfc6d845f7bdb45e8a8bcc41fbe8bea"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
    "summary": "Health care stocks increased late Wednesday afternoon with the NYSE Health Care Index and the Health",
    "url": "https://finnhub.io/api/news?id=e322da80ebcd7323ee245b2aefb0c6f99b13e888875ce267e4867d2c7d4f50c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760557639,
      "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
      "id": 137097113,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Health care stocks increased late Wednesday afternoon with the NYSE Health Care Index and the Health",
      "url": "https://finnhub.io/api/news?id=e322da80ebcd7323ee245b2aefb0c6f99b13e888875ce267e4867d2c7d4f50c6"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Medical ...",
    "summary": "Abbott Laboratories (ABT) reports robust earnings with significant contributions from medical devices and new product innovations, despite challenges in the diagnostics segment.",
    "url": "https://finnhub.io/api/news?id=cb36907be3623b132ddddd25ead211fc0971b3e1d3df7cd618bb080fb9dcace7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760554889,
      "headline": "Abbott Laboratories (ABT) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Medical ...",
      "id": 137095762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (ABT) reports robust earnings with significant contributions from medical devices and new product innovations, despite challenges in the diagnostics segment.",
      "url": "https://finnhub.io/api/news?id=cb36907be3623b132ddddd25ead211fc0971b3e1d3df7cd618bb080fb9dcace7"
    }
  },
  {
    "ts": null,
    "headline": "Abbott narrows outlook, Australian stocks react to US-China trade",
    "summary": "Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Abbott Laboratories (ABT) shares slipping after the company narrowed its full-year guidance, Amphenol (APH) receiving an upgrade to Buy, and Australian stocks — like Australian Oilseeds (COOT) — are reacting to the rare earth trade tensions between the US and China. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=6a4f842f5cae1cf19d720e8cdde86aadc113eb70b92955f1198bf6bf9419d067",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760551839,
      "headline": "Abbott narrows outlook, Australian stocks react to US-China trade",
      "id": 137095763,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Abbott Laboratories (ABT) shares slipping after the company narrowed its full-year guidance, Amphenol (APH) receiving an upgrade to Buy, and Australian stocks — like Australian Oilseeds (COOT) — are reacting to the rare earth trade tensions between the US and China. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=6a4f842f5cae1cf19d720e8cdde86aadc113eb70b92955f1198bf6bf9419d067"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Misses Third-Quarter Sales View, Narrows Full-Year Profit Outlook",
    "summary": "Abbott Laboratories' (ABT) third-quarter sales fell short of Wall Street's forecasts as diagnostics",
    "url": "https://finnhub.io/api/news?id=d9b8fe68c0e5f992434c03ecdd0e2b49ccd75f369dbf25cb5abc4022ff6360d0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760549736,
      "headline": "Abbott Misses Third-Quarter Sales View, Narrows Full-Year Profit Outlook",
      "id": 137095764,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories' (ABT) third-quarter sales fell short of Wall Street's forecasts as diagnostics",
      "url": "https://finnhub.io/api/news?id=d9b8fe68c0e5f992434c03ecdd0e2b49ccd75f369dbf25cb5abc4022ff6360d0"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
    "summary": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=f70e288b4bb92b0383b9d11ef6ab595e592eb007732960f6a2c875e9428bfa5f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760545980,
      "headline": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
      "id": 137137578,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f70e288b4bb92b0383b9d11ef6ab595e592eb007732960f6a2c875e9428bfa5f"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Stock Drops Despite Earnings. Baby-Formula Sales Took a Hit.",
    "summary": "Abbott Laboratories  shares were down on Wednesday despite an apparently solid earnings report, after sales of its baby formula dropped in the U.S.  Adjusted diluted earnings for the quarter were $1.30 per share, in line with the FactSet consensus estimate.  Sales were $11.37 billion, nearly in line with the $11.39 billion analyst consensus, and management signaled that Wall Street’s expectations for profits are on target.",
    "url": "https://finnhub.io/api/news?id=0b3ae165c984be61efb20e115a8730e54e7f27e782cbd8f19bc110e32f8fae37",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760544900,
      "headline": "Abbott Stock Drops Despite Earnings. Baby-Formula Sales Took a Hit.",
      "id": 137095765,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories  shares were down on Wednesday despite an apparently solid earnings report, after sales of its baby formula dropped in the U.S.  Adjusted diluted earnings for the quarter were $1.30 per share, in line with the FactSet consensus estimate.  Sales were $11.37 billion, nearly in line with the $11.39 billion analyst consensus, and management signaled that Wall Street’s expectations for profits are on target.",
      "url": "https://finnhub.io/api/news?id=0b3ae165c984be61efb20e115a8730e54e7f27e782cbd8f19bc110e32f8fae37"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Health Giant Abbott Labs Skids On Mixed Report. But One Segment Shined.",
    "summary": "S&P 500 Health Giant Abbott Labs Skids On Mixed Report. But One Segment Shined.",
    "url": "https://finnhub.io/api/news?id=8042c87739c8835414ef332e7c6b2991733bd318ed03a82de8261522b0499bcb",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760544541,
      "headline": "S&P 500 Health Giant Abbott Labs Skids On Mixed Report. But One Segment Shined.",
      "id": 137109014,
      "image": "",
      "related": "ABT",
      "source": "DowJones",
      "summary": "S&P 500 Health Giant Abbott Labs Skids On Mixed Report. But One Segment Shined.",
      "url": "https://finnhub.io/api/news?id=8042c87739c8835414ef332e7c6b2991733bd318ed03a82de8261522b0499bcb"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: ASML Shares Rise After 2026 Outlook; Bank of America Shares Rise After EPS, Revenue Beats",
    "summary": "All three major US stock indexes were up in late-morning trading Wednesday thanks in part to a slew",
    "url": "https://finnhub.io/api/news?id=39b4768ad2701d2ef014aa7944ed8487855623a5b54ceb746dbecf666353e7c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760543208,
      "headline": "Top Midday Stories: ASML Shares Rise After 2026 Outlook; Bank of America Shares Rise After EPS, Revenue Beats",
      "id": 137093960,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were up in late-morning trading Wednesday thanks in part to a slew",
      "url": "https://finnhub.io/api/news?id=39b4768ad2701d2ef014aa7944ed8487855623a5b54ceb746dbecf666353e7c5"
    }
  },
  {
    "ts": null,
    "headline": "NVST or ABT: Which Is the Better Value Stock Right Now?",
    "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=596c8fc8b251d929396e3b220d8bfbbb77d42c5c3d53c8ab716a82351c59a0bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760542804,
      "headline": "NVST or ABT: Which Is the Better Value Stock Right Now?",
      "id": 137095766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=596c8fc8b251d929396e3b220d8bfbbb77d42c5c3d53c8ab716a82351c59a0bb"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More",
    "summary": "Bank of America and Morgan Stanley beat earnings estimates, while ASML, the Dutch semiconductor-equipment maker, posts better-than-expected third-quarter earnings and issues an upbeat forecast.",
    "url": "https://finnhub.io/api/news?id=0fe8d4ceb6d675408191322367982dc2d2dc3a9f01c3e52220d57bc66b855c4f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760541600,
      "headline": "These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More",
      "id": 137093660,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Bank of America and Morgan Stanley beat earnings estimates, while ASML, the Dutch semiconductor-equipment maker, posts better-than-expected third-quarter earnings and issues an upbeat forecast.",
      "url": "https://finnhub.io/api/news?id=0fe8d4ceb6d675408191322367982dc2d2dc3a9f01c3e52220d57bc66b855c4f"
    }
  },
  {
    "ts": null,
    "headline": "Pre-Markets in Green on Strong Q3 Bank Earnings",
    "summary": "Pre-Markets in Green on Strong Q3 Bank Earnings.",
    "url": "https://finnhub.io/api/news?id=f894f7572925f4423fa8be58bae50fb35e1f2ae43ae2c7b6b4c01e6e077c045b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760541480,
      "headline": "Pre-Markets in Green on Strong Q3 Bank Earnings",
      "id": 137095739,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Pre-Markets in Green on Strong Q3 Bank Earnings.",
      "url": "https://finnhub.io/api/news?id=f894f7572925f4423fa8be58bae50fb35e1f2ae43ae2c7b6b4c01e6e077c045b"
    }
  },
  {
    "ts": null,
    "headline": "Regional bank stocks mixed on earnings, Apple to use M5 chip",
    "summary": "Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including regional banks Citizens Financial Group (CFG), First Horizon (FHN), and PNC Financial Services (PNC) after reporting their quarterly earnings results; Apple (AAPL) updating products with its new M5 chip; and Abbott Laboratories (ABT) cutting its 2025 guidance. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=f38fb6d6bff90ab2e9d4cf6497f6a745dc36dcd57b98b94574835e603d2b7674",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760540232,
      "headline": "Regional bank stocks mixed on earnings, Apple to use M5 chip",
      "id": 137093695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including regional banks Citizens Financial Group (CFG), First Horizon (FHN), and PNC Financial Services (PNC) after reporting their quarterly earnings results; Apple (AAPL) updating products with its new M5 chip; and Abbott Laboratories (ABT) cutting its 2025 guidance. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=f38fb6d6bff90ab2e9d4cf6497f6a745dc36dcd57b98b94574835e603d2b7674"
    }
  },
  {
    "ts": null,
    "headline": "Pre-markets Strengthen on Solid Q3 Bank Earnings",
    "summary": "We also see another better-than-expected manufacturing report out of New York State.",
    "url": "https://finnhub.io/api/news?id=1ecdc7891ceaf22213c5e3237e7d14969dff66e24b9bef037326567dca152b92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760538780,
      "headline": "Pre-markets Strengthen on Solid Q3 Bank Earnings",
      "id": 137095740,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We also see another better-than-expected manufacturing report out of New York State.",
      "url": "https://finnhub.io/api/news?id=1ecdc7891ceaf22213c5e3237e7d14969dff66e24b9bef037326567dca152b92"
    }
  },
  {
    "ts": null,
    "headline": "Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs",
    "summary": "ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.",
    "url": "https://finnhub.io/api/news?id=eb6368742c0329bb5b29fe5e0fbc2bb0a6608630d49a3b190c7998df4dce0c4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760537520,
      "headline": "Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs",
      "id": 137094068,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.",
      "url": "https://finnhub.io/api/news?id=eb6368742c0329bb5b29fe5e0fbc2bb0a6608630d49a3b190c7998df4dce0c4d"
    }
  },
  {
    "ts": null,
    "headline": "1 No-Brainer Dividend Stock to Buy and Hold Forever",
    "summary": "This is about as safe as a dividend can be.",
    "url": "https://finnhub.io/api/news?id=b24605188f26d4e67a146574971befab67be88b0c934f0b092c8104ecd786f92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760535900,
      "headline": "1 No-Brainer Dividend Stock to Buy and Hold Forever",
      "id": 137094070,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "This is about as safe as a dividend can be.",
      "url": "https://finnhub.io/api/news?id=b24605188f26d4e67a146574971befab67be88b0c934f0b092c8104ecd786f92"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript",
    "summary": "Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call October 15, 2025 9:00 AM EDTCompany ParticipantsMichael Comilla - Vice President of Investor...",
    "url": "https://finnhub.io/api/news?id=d0e8d11c6f757d9bafacd1d8f8202cd4908c7f1aa1be944e01301291103b0fe1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760535399,
      "headline": "Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript",
      "id": 137095008,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call October 15, 2025 9:00 AM EDTCompany ParticipantsMichael Comilla - Vice President of Investor...",
      "url": "https://finnhub.io/api/news?id=d0e8d11c6f757d9bafacd1d8f8202cd4908c7f1aa1be944e01301291103b0fe1"
    }
  },
  {
    "ts": null,
    "headline": "Here's What Key Metrics Tell Us About Abbott (ABT) Q3 Earnings",
    "summary": "Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=e392106c644f0881958f9d7bce180f182a0cca60dc7e27299257f83c5d0f7a43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760535002,
      "headline": "Here's What Key Metrics Tell Us About Abbott (ABT) Q3 Earnings",
      "id": 137094071,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=e392106c644f0881958f9d7bce180f182a0cca60dc7e27299257f83c5d0f7a43"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Amazon Hints At Job Cuts In AI-Driven Restructure",
    "summary": "Amazon (AMZN) is prepping for layoffs as it spends big on AI.",
    "url": "https://finnhub.io/api/news?id=e2063f8e4c04d2737a5462c12dc7ee112ba42ac605350ab972d11fda5a89e823",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760534283,
      "headline": "Wall Street Lunch: Amazon Hints At Job Cuts In AI-Driven Restructure",
      "id": 137094935,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1252468735/image_1252468735.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Amazon (AMZN) is prepping for layoffs as it spends big on AI.",
      "url": "https://finnhub.io/api/news?id=e2063f8e4c04d2737a5462c12dc7ee112ba42ac605350ab972d11fda5a89e823"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Q3 Earnings Meet Estimates",
    "summary": "Abbott (ABT) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=4fd2c751b50dce790aaf7191dc05c29922dcb9ad1cd43208ac015e2a2687ff40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760532001,
      "headline": "Abbott (ABT) Q3 Earnings Meet Estimates",
      "id": 137094072,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=4fd2c751b50dce790aaf7191dc05c29922dcb9ad1cd43208ac015e2a2687ff40"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway.",
    "summary": "Abbott Laboratories  stock fell after a solid earnings report from the medical devices maker early Wednesday.  The company, which also makes nutrition products, narrowed its guidance for the second time this year.  It now expects 2025 adjusted earnings per share between $5.12 and $5.18, compared with previous guidance of between $5.10 and $5.20 a share.",
    "url": "https://finnhub.io/api/news?id=8c55114a29377adcd92fc644895f96c48a11eff701f1455334334f156c8aeb05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760531100,
      "headline": "Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway.",
      "id": 137094073,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories  stock fell after a solid earnings report from the medical devices maker early Wednesday.  The company, which also makes nutrition products, narrowed its guidance for the second time this year.  It now expects 2025 adjusted earnings per share between $5.12 and $5.18, compared with previous guidance of between $5.10 and $5.20 a share.",
      "url": "https://finnhub.io/api/news?id=8c55114a29377adcd92fc644895f96c48a11eff701f1455334334f156c8aeb05"
    }
  },
  {
    "ts": null,
    "headline": "Abbott reports in-line third-quarter results, affirms guidance; shares slip",
    "summary": "Investing.com -- Abbott Laboratories shares slid over 2% in premarket trading Wednesday after the medical devices maker reported in-line third-quarter earnings and sales just shy of the consensus forecast.",
    "url": "https://finnhub.io/api/news?id=ee3de279d4488993b20f2c456d30ec18157e4ffec803dd4feb946a5c6532ebd8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760530286,
      "headline": "Abbott reports in-line third-quarter results, affirms guidance; shares slip",
      "id": 137094074,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Investing.com -- Abbott Laboratories shares slid over 2% in premarket trading Wednesday after the medical devices maker reported in-line third-quarter earnings and sales just shy of the consensus forecast.",
      "url": "https://finnhub.io/api/news?id=ee3de279d4488993b20f2c456d30ec18157e4ffec803dd4feb946a5c6532ebd8"
    }
  },
  {
    "ts": null,
    "headline": "Abbott CEO: ‘We’re right on time’ to the PFA party",
    "summary": "As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.",
    "url": "https://finnhub.io/api/news?id=470035f4dae368f617bb6f009f5b96189076d09a76576684387e6abf67051d74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760529907,
      "headline": "Abbott CEO: ‘We’re right on time’ to the PFA party",
      "id": 137095702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.",
      "url": "https://finnhub.io/api/news?id=470035f4dae368f617bb6f009f5b96189076d09a76576684387e6abf67051d74"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Reports Q3 In Line With Expectations",
    "summary": "Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30 per share was in line with analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=e744bf700a53b72033bef666b364e0920fe2c8d647a36c7f7105d0ebf89a05b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760529381,
      "headline": "Abbott Laboratories (NYSE:ABT) Reports Q3 In Line With Expectations",
      "id": 137094075,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30 per share was in line with analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=e744bf700a53b72033bef666b364e0920fe2c8d647a36c7f7105d0ebf89a05b5"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Labs Posts Higher Sales, Reaffirms Outlook",
    "summary": "Abbott Laboratories backed its full-year outlook after posting higher sales in the third quarter, boosted by sales of its nutrition shakes and drinks for adults",
    "url": "https://finnhub.io/api/news?id=5a3aa7b05ea90e61a329843205cf5a4d50a2941fcda35ae6b23a88a6a02d2f58",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760529300,
      "headline": "Abbott Labs Posts Higher Sales, Reaffirms Outlook",
      "id": 137094076,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories backed its full-year outlook after posting higher sales in the third quarter, boosted by sales of its nutrition shakes and drinks for adults",
      "url": "https://finnhub.io/api/news?id=5a3aa7b05ea90e61a329843205cf5a4d50a2941fcda35ae6b23a88a6a02d2f58"
    }
  },
  {
    "ts": null,
    "headline": "Abbott: Q3 Earnings Snapshot",
    "summary": "The results matched Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was also for earnings of $1.30 per share. The maker of infant formula, medical devices and drugs posted revenue of $11.37 billion in the period, which fell short of Street forecasts.",
    "url": "https://finnhub.io/api/news?id=55822ace2b44ee10744a0a6fb303e76e44ba15df1cc3fce2792fd9d4d8275e95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760528323,
      "headline": "Abbott: Q3 Earnings Snapshot",
      "id": 137094077,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The results matched Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was also for earnings of $1.30 per share. The maker of infant formula, medical devices and drugs posted revenue of $11.37 billion in the period, which fell short of Street forecasts.",
      "url": "https://finnhub.io/api/news?id=55822ace2b44ee10744a0a6fb303e76e44ba15df1cc3fce2792fd9d4d8275e95"
    }
  },
  {
    "ts": null,
    "headline": "Oral Clinical Nutrition Analysis Report 2025: Market is Dominated by Nestlé, Abbott, and Danone through Innovation, Plant-Based Formulations, and Expanding Distribution Channels - Forecast to 2033",
    "summary": "The global oral clinical nutrition market is expanding, driven by aging populations, rising chronic diseases, and nutrition awareness. Opportunities include tailored formulas for specific diseases, integration into healthcare, and regional growth, particularly in Asia Pacific. Challenges remain in costs and awareness in developing regions.Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The \"Oral Clinical Nutrition Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Pl",
    "url": "https://finnhub.io/api/news?id=324a367ab0529e37133cec35e66cdffac1ec2a487fc1c2a711f318420d33ef6b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760528220,
      "headline": "Oral Clinical Nutrition Analysis Report 2025: Market is Dominated by Nestlé, Abbott, and Danone through Innovation, Plant-Based Formulations, and Expanding Distribution Channels - Forecast to 2033",
      "id": 137094078,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The global oral clinical nutrition market is expanding, driven by aging populations, rising chronic diseases, and nutrition awareness. Opportunities include tailored formulas for specific diseases, integration into healthcare, and regional growth, particularly in Asia Pacific. Challenges remain in costs and awareness in developing regions.Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The \"Oral Clinical Nutrition Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Pl",
      "url": "https://finnhub.io/api/news?id=324a367ab0529e37133cec35e66cdffac1ec2a487fc1c2a711f318420d33ef6b"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Bank of America, Morgan Stanley, LVMH, and ASML stocks jump on strong results",
    "summary": "Third quarter earnings season is just beginning, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finnhub.io/api/news?id=e0e2af8486976c0129afddf6bae80500263450dedc18f3b6f31ddb876f4b268d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760527831,
      "headline": "Earnings live: Bank of America, Morgan Stanley, LVMH, and ASML stocks jump on strong results",
      "id": 137093833,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Third quarter earnings season is just beginning, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
      "url": "https://finnhub.io/api/news?id=e0e2af8486976c0129afddf6bae80500263450dedc18f3b6f31ddb876f4b268d"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance",
    "summary": "Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2025.",
    "url": "https://finnhub.io/api/news?id=30d9a9e7b56b5d94ef8727141d7031acc2d9ee70e92ea562a4f2cf372b6d588a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760527800,
      "headline": "Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance",
      "id": 137094080,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2025.",
      "url": "https://finnhub.io/api/news?id=30d9a9e7b56b5d94ef8727141d7031acc2d9ee70e92ea562a4f2cf372b6d588a"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Rise Pre-Bell as Traders Digest Latest US-China Trade Tensions, Await Earnings",
    "summary": "The main US stock measures were pointing higher in Wednesday's premarket activity as traders digest",
    "url": "https://finnhub.io/api/news?id=530aebdb8f9d931cae139c3a19e0da8e59e4ab9214dc5a9b7f8f9725eb2c8370",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760526344,
      "headline": "Stocks Rise Pre-Bell as Traders Digest Latest US-China Trade Tensions, Await Earnings",
      "id": 137094081,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The main US stock measures were pointing higher in Wednesday's premarket activity as traders digest",
      "url": "https://finnhub.io/api/news?id=530aebdb8f9d931cae139c3a19e0da8e59e4ab9214dc5a9b7f8f9725eb2c8370"
    }
  },
  {
    "ts": null,
    "headline": "How the Recent Abbott Earnings Beat Shapes the Stock’s 2025 Value Outlook",
    "summary": "Thinking about what to do with Abbott Laboratories stock? You’re definitely not alone. This healthcare giant has seen its share of headlines, and for investors, the story is far from over. The shares recently closed at $133.27, which reflects both fresh optimism and some caution from the market. In the short term, Abbott’s stock has been relatively steady with a 0.2% gain over the past week and a slight dip of -0.3% over the last month. The longer view is much more impressive. Since the start...",
    "url": "https://finnhub.io/api/news?id=16ccdf792a9c5336bf4f58e623e2fc4b7c1a271573b2416dbac9b1102bc45447",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760523086,
      "headline": "How the Recent Abbott Earnings Beat Shapes the Stock’s 2025 Value Outlook",
      "id": 137094082,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Thinking about what to do with Abbott Laboratories stock? You’re definitely not alone. This healthcare giant has seen its share of headlines, and for investors, the story is far from over. The shares recently closed at $133.27, which reflects both fresh optimism and some caution from the market. In the short term, Abbott’s stock has been relatively steady with a 0.2% gain over the past week and a slight dip of -0.3% over the last month. The longer view is much more impressive. Since the start...",
      "url": "https://finnhub.io/api/news?id=16ccdf792a9c5336bf4f58e623e2fc4b7c1a271573b2416dbac9b1102bc45447"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Labs confirms full-year 2025 guidance",
    "summary": "Global sales for Q3 were $11.4bn. Reported sales increased 6.9%.Medical Devices achieved double-digit growth generating sales of $5.4bn, up 12.5% organically . Blood glucose meter sales increased...",
    "url": "https://finnhub.io/api/news?id=d42c782125c57777621f4f81645409338cf305bc0358ad63fcfb56ac4c5bb4ee",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760518295,
      "headline": "Abbott Labs confirms full-year 2025 guidance",
      "id": 137093007,
      "image": "",
      "related": "ABT",
      "source": "Finnhub",
      "summary": "Global sales for Q3 were $11.4bn. Reported sales increased 6.9%.Medical Devices achieved double-digit growth generating sales of $5.4bn, up 12.5% organically . Blood glucose meter sales increased...",
      "url": "https://finnhub.io/api/news?id=d42c782125c57777621f4f81645409338cf305bc0358ad63fcfb56ac4c5bb4ee"
    }
  },
  {
    "ts": null,
    "headline": "Bank Earnings, Musk Pay Dispute, More Fed Speakers: Still to Come This Week",
    "summary": "The first big week of earnings season continues, with more Wall Street results due Wednesday from Bank of America and Morgan Stanley. Analysts see S&P 500 companies on track for a ninth consecutive quarter of earnings growth.",
    "url": "https://finnhub.io/api/news?id=ca063836e5f3ac8be317abf4dc1345a0f18c216410f05be0a007bc5625d6f92a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760512753,
      "headline": "Bank Earnings, Musk Pay Dispute, More Fed Speakers: Still to Come This Week",
      "id": 137094083,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The first big week of earnings season continues, with more Wall Street results due Wednesday from Bank of America and Morgan Stanley. Analysts see S&P 500 companies on track for a ninth consecutive quarter of earnings growth.",
      "url": "https://finnhub.io/api/news?id=ca063836e5f3ac8be317abf4dc1345a0f18c216410f05be0a007bc5625d6f92a"
    }
  }
]